Lange J

No ORCID on file · 6 papers in corpus · active 2002-2025

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 4
  • adenomyosis 1
2025
Population characteristics of intrauterine device users in real-world clinical practice across Europe - insights from the EURAS-LCS12 study.
Contraception and reproductive medicine ·doi:10.1186/s40834-025-00353-8

BackgroundThe European Active Surveillance Study of LCS12 (EURAS-LCS12) investigates effectiveness and safety of intrauterine devices (IUDs) in routine clinical practice. Here, we aim to characterise the general population of IUD users acro…

2020
The 13th European Colorectal Congress (#ECCStGallen), 1-5 December 2019, St Gallen, Switzerland: Congress Report.
Techniques in coloproctology ·doi:10.1007/s10151-020-02211-y
article 2014
Surgical outcome of deep infiltrating colorectal endometriosis in a multidisciplinary setting
Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3257-x

BackgroundEndometriosis as a benign disease appears frequently in premenopausal women with highly variable symptoms. In advanced stages bowel involvement is common. In symptomatic disease the adequate treatment requires complete resection o…

other 2003
[COX-2-expression in extragenital endometriosis lesions as a novel therapeutical approach?]
Zentralblatt fur Gynakologie ·doi:10.1055/s-2003-42279

OBJECTIVE: Extragenital endometriosis is a rare form of endometriosis. Due to its invasive and metastatic properties it resembles some features of malignant tumours. Cyclooxygenase (COX)-2 is a rate-limiting enzyme in the biosynthesis of pr…

article 2002
Endometriumkarzinom unter GnRH-Analoga-Therapie bei Endometriose
Zentralblatt fur Gynakologie ·doi:10.1055/s-2002-38912

Endometriosis affects a 10 % of women during their reproductive years. Unequoral statistics concerning the incidence of adenomyosis are not available although a combined occurrence of both diseases is found in a 20 % of cases. The risk that…

article 2002
Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report
Archives of gynecology and obstetrics ·doi:10.1007/s00404-002-0435-z

Danazol, an inhibitor of pituitary gonadotropin with weak androgenic effect, is currently being used for the treatment of endometriosis. In contrast to other C17 alkylated anabolic steroids, it has been rarely associated with the occurrence…